NCKAP1 can inhibit tumor cell growth via multiple pathways, including ribosomal signaling, oxidative phosphorylation, TGF-β, EMT-related, and RB1/P53 signaling pathways [147, 151]. The gene discussed is NCKAP1; the disease is neoplasm.